Orthofix shares ended the last trading session 5.1% higher at $9.78 on higher-than-average volume, driven by investor optimism over the company's solid first quarter of 2026 results. The medical device maker reported a loss per share of 52 cents and revenues of $196.7 million for the quarter. For the upcoming report, analysts expect a quarterly loss of $0.03 per share on revenues of $209.51 million, representing a 3.1% revenue increase year over year. The consensus earnings estimate for the quarter has remained unchanged over the last 30 days, and the stock currently carries a Zacks Rank of 3, or Hold.
Orthofix Medical Incstrong Q1 2026 results and investor optimism
Mettler-Toledo International Inc